Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay – evaluation of a new HIV assay
- 5 August 2013
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 25 (4) , 267-272
Abstract
A new fourth-generation HIV Ag/Ab electrochemiluminescence immunoassay for screening of HIV infection, the Elecsys® HIV Combi PT (Roche Diagnostics, Penzberg, Germany) assay, is going to be commercially available in clinical laboratories in China. This assay was evaluated and compared with two commonly used assays: Elecsys® HIV Combi assay and the Livzon anti-HIV-1/2 ELISA. Commercially available panels and 30 established HIV infection samples were tested to evaluate the sensitivity. In addition, a total of 675 routine clinical samples were collected and tested in West China Hospital to compare the specificity. Any reactive result from a screening test was retested and all reactive retested samples were confirmed with Western blot assay, Elecsys® HIV Ag test, Elecsys® HIV Ag confirmatory test or HIV-1 RNA NAT testing. According to the results of the HIV seroconversion panels, the Elecsys® HIV Combi PT could detect seroconversion at the same bleed or at least one bleed earlier compared to the other two assays. Among the 675 clinical samples, most results were consistent except for one specimen with a false-negative result using Elecsys® HIV Combi assay. In conclusion, the Elecsys® HIV Combi PT has shown satisfactory sensitivity and specificity to be a screening test for HIV infection.Keywords
This publication has 13 references indexed in Scilit:
- Performance evaluation of a new fourth-generation HIV combination antigen–antibody assayMedical Microbiology and Immunology, 2012
- False-Positive Human Immunodeficiency Virus Enzyme Immunoassay Results in Pregnant WomenPLOS ONE, 2011
- Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, ZimbabweBMC Infectious Diseases, 2011
- False-Positive Rate of a “Fourth-Generation” HIV Antigen/Antibody Combination Assay in an Area of Low HIV PrevalenceClinical and Vaccine Immunology, 2010
- Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2Journal of Virological Methods, 2010
- Performance evaluation of the ADVIA Centaur® HIV Ag/Ab Combo assayJournal of Virological Methods, 2010
- Assessment of the Ability of a Fourth-Generation Immunoassay for Human Immunodeficiency Virus (HIV) Antibody and p24 Antigen To Detect both Acute and Recent HIV Infections in a High-Risk SettingJournal of Clinical Microbiology, 2009
- Clinical Performance Evaluation of Four Automated Chemiluminescence Immunoassays for Hepatitis C Virus Antibody DetectionJournal of Clinical Microbiology, 2008
- Performance of Two Commercial Immunochromatographic Assays for Rapid Detection of Antibodies Specific to Human Immunodeficiency Virus Types 1 and 2 in Serum and Urine Samples in a Rural Community-Based Research Setting (Rakai, Uganda)Clinical and Vaccine Immunology, 2007
- Use of an Acute Seroconversion Panel To Evaluate a Third-Generation Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus-Specific Antibodies Relative to Multiple Other AssaysJournal of Clinical Microbiology, 2006